• 研究課題をさがす
  • 研究者をさがす
  • KAKENの使い方
  1. 課題ページに戻る

2023 年度 実施状況報告書

Prevalence and Genotype Distribution of HDV using in-house developed ELISA in both serum and dried blood spots samples of pregnant women and their newborns in Siem Reap, Cambodia

研究課題

研究課題/領域番号 23K16303
研究機関広島大学

研究代表者

KO KO  広島大学, 医系科学研究科(医), 助教 (80910299)

研究期間 (年度) 2023-04-01 – 2026-03-31
キーワードHepatitis D Virus / Cambodia / ELISA / Screening
研究実績の概要

I developed and validated an in-house direct ELISA method for detecting anti-HDV among 67 HBsAg positive pregnant women's stock serum collected in 2021 in Cambodia. Compared to a commercially available kit, the sensitivity was 50%, and the specificity was 95.4%. The overall anti-HDV prevalence among HBsAg positives was 5.97% (4/67). Subsequently, positive samples were tested for HDV RNA using nested RT-PCR with in-house developed universal primer sets, revealing that only 2 were HDV RNA positive (2.98%). Further amplification confirmed both belonged to HDV genotype 1. The study results were presented at APASL 2023 and the Japan Society of Hepatology conference in Otani. Currently, I am conducting a trial experiment on anti-HDV detection using dried blood spot (DBS) samples.

現在までの達成度 (区分)
現在までの達成度 (区分)

1: 当初の計画以上に進展している

理由

Over fifty percent of the project has been completed after repeated trial and experiments on development of in-house Direct ELISA method. Subsequently, the trial experiment on anti-HDV detection by in-house direct ELISA method using dried blood spot samples is on track and I expect to develop and validate before September 2024. The, I will subsequently continue for anti-HDV detection among all 67 positives pregnant women DBS and their children DBS. The result of the study have been presented as poster in both Japan Society of Hepatology conference in Otani and APASL Kyoto 2024.

今後の研究の推進方策

Subsequently after successful development and validation of In-house Direct ELISA based anti-HDV detection, I am now on track in developing in-house Direct ELISA based detection of anti-HDV using Dried Blood Spot samples, and planning to perform anti-HDV screening among children. The technique development is expected to complete by September 2024. Once the in-house method is validated, the anti-HDV screening will be performed in children using DBS samples.

次年度使用額が生じた理由

I canceled one conference to attend inside Japan unfortunately, because of tight schedule. That why there is a remaining amount for last year budget but, I will purchase the reagents required for the development of in-house ELISA for DBS this year.

  • 研究成果

    (2件)

すべて 2023

すべて 学会発表 (2件) (うち国際学会 2件)

  • [学会発表] Prevalence of Anti-HDV Among 67 HBsAg positive Pregnant Women in Siem Reap, Cambodia2023

    • 著者名/発表者名
      Golda Akuffo, Ko Ko, Bunthen E, Serge Ouoba, Aya Sugiyama, Tomoyuki Akita, Kazuaki Takashi, Junko Tanaka
    • 学会等名
      JSH International Liver Conference 2023
    • 国際学会
  • [学会発表] Prevalence of Anti-HDV Among 67 HBsAg positive Pregnant Women in Siem Reap, Cambodia2023

    • 著者名/発表者名
      Golda Akuffo, Ko Ko, Bunthen E, Serge Ouoba, Aya Sugiyama, Tomoyuki Akita, Kazuaki Takashi, Junko Tanaka
    • 学会等名
      APASL Kyoto 2023
    • 国際学会

URL: 

公開日: 2024-12-25  

サービス概要 検索マニュアル よくある質問 お知らせ 利用規程 科研費による研究の帰属

Powered by NII kakenhi